General Announcement::Announcement by TMC Life Sciences Berhad - Q2 2025 Results Announcement

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$120M5.5%N280531 - SGXF52537366 - V2AB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED S$160M4.65%N291029 - SGXF42557540 - 9BQB
THOMSON MED S$155M5.25%N270513 - SGXF30304939 - HUHB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
10-Feb-2025 17:54:51
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Berhad - Q2 2025 Results Announcement
Announcement Reference
SG250210OTHRWTZS
Submitted By (Co./ Ind. Name)
Dr Melvin Heng Jun Li
Designation
Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below)
Pls refer to the attached.

Attachments

TMCLS Announcement_Q2 2025-Dec 24.pdf
Total size =276K